Nuvectis Pharma, Inc. (NVCT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Nuvectis Pharma, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -6.23x | -4.87x | -5.83x | -4.97x | -3.21x | -4133.28x |
| P/B Ratio | 8.94x | 9.53x | 10.63x | 6.68x | -3.75x | -4133.28x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 2.38x | 2.09x | 2.75x | 3.30x | 2.41x | 0.00x |
| Quick Ratio | 2.38x | 2.09x | 2.75x | 3.30x | 2.41x | 0.00x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..